Abstract
Background17q12 deletion syndrome encompasses a broad constellation of clinical phenotypes, including renal magnesium wasting, maturity-onset diabetes of the young (MODY), renal cysts, genitourinary malformations, and neuropsychiatric illness. Manifestations outside of the renal, endocrine, and nervous systems have not been well described.Case presentationWe report a 62-year-old male referred to the Undiagnosed Diseases Program (UDP) at the National Institutes of Health (NIH) who presented with persistent hypermagnesiuric hypomagnesemia and was found to have a 17q12 deletion. The patient exhibited several known manifestations of the syndrome, including severe hypomagnesemia, renal cysts, diabetes and cognitive deficits. Coronary CT revealed extensive coronary calcifications, with a coronary artery calcification score of 12,427. Vascular calcifications have not been previously reported in this condition. We describe several physiologic mechanisms and a review of literature to support the expansion of the 17q12 deletion syndrome to include vascular calcification.ConclusionExtensive coronary and vascular calcifications may be an extension of the 17q12 deletion phenotype, particularly if hypomagnesemia and hyperparathyroidism are prevalent. In patients with 17q12 deletions involving HNF1B, hyperparathyroidism and hypomagnesemia may contribute to significant cardiovascular risk.
Highlights
17q12 deletion syndrome encompasses a broad constellation of clinical phenotypes, including renal magnesium wasting, maturity-onset diabetes of the young (MODY), renal cysts, genitourinary malformations, and neuropsychiatric illness
Extensive coronary and vascular calcifications may be an extension of the 17q12 deletion phenotype, if hypomagnesemia and hyperparathyroidism are prevalent
In patients with 17q12 deletions involving Hepatocyte Nuclear Factor 1B (HNF1B), hyperparathyroidism and hypomagnesemia may contribute to significant cardiovascular risk
Summary
Extensive coronary and vascular calcifications may be an extension of the 17q12 deletion phenotype, if hypomagnesemia and hyperparathyroidism are prevalent.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have